...
首页> 外文期刊>Frontiers in Molecular Biosciences >Update in Laboratory Diagnosis of Thalassemia
【24h】

Update in Laboratory Diagnosis of Thalassemia

机译:日元血症实验室诊断的更新

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Alpha-, beta-thalassemias and some abnormal hemoglobins such as hemoglobin E (Hb E) and Hb Constant Spring (Hb CS) are common in Southeast Asia and southern part of China. The complex gene-gene interaction leads to many thalassemic diseases including homozygous β-thalassemia, β-thalassemia/Hb E and Hb Bart’s hydrops fetalis. Laboratory diagnosis of thalassemia requires a number of tests including red blood cell indices, hemoglobin (Hb) and DNA analysis. Thalassemic red cells analysis with an automated hematology analyzer is a primary screening for thalassemia since microcytosis and decreased Hb content of red blood cells is a hallmark of all thalassemic red cells. However, these two red blood cell indices cannot discriminate between thalassemia trait and iron deficiency or between alpha-, beta -thalassemic conditions. Today Hb analysis may be carried out by either automatic high performance liquid chromatography (HPLC) or capillary zone electrophoresis (CE) system. These two systems give both qualitative and quantitative analysis of Hb components and help to do thalassemia prenatal and postnatal diagnosis within short period. Both systems have a good correlation but the interpretation under the CE system should be caution because Hb A2 is clearly separated from Hb E. Especially in case with alpha thalassemia gene interaction, it affects the amount of Hb A2/E. The identification of different thalassemia genotypes can be revealed by the intensities between alpha-/beta-globin chains or alpha-/beta-mRNA ratios. However, none of these techniques can accurately diagnose specific thalassemia genotype. Specific thalassemia mutation can be carried out by DNA analysis. Various molecular techniques have been used for point mutation detection in beta-thalassemia and large-deletion detection in alpha-thalassemia. All of these techniques have some advantages and disadvantages. Recently, screening for both alpha- and beta- thalassemia genes by Next Generation Sequencing (NGS) has been introduced. This technique gives an accurate diagnosis of thalassemia that may be misdiagnose by conventional technique. The major limitation to use NGS for the screening of thalassemia is its cost which is still expensive. All service labs were highly recommend to select the technique(s) they are most familiar and most economic one for their routine use.
机译:α-,β-秋季复苏和一些异常的血红蛋白,如血红蛋白E(HB e)和Hb恒星恒星(Hb Cs)是常见的中国和中国南部。复杂的基因相互作用导致许多初始血症疾病,包括纯合β-地中海贫血,β-zhalassemia / Hb E和HB Bart的Hydrops Fetalis。地中海贫血的实验室诊断需要许多测试,包括红细胞指数,血红蛋白(HB)和DNA分析。随着自动血液学分析仪分析的炎症红细胞分析是初级筛查,因为半肾病和红细胞的HB含量降低是所有炎症红细胞的标志。然而,这两个红细胞索引不能区分地中海贫血性状和缺铁或α-,β-邻阶段性条件。如今,HB分析可以通过自动高效液相色谱(HPLC)或毛细管区电泳(CE)系统进行。这两种系统对Hb组件进行了定性和定量分析,并在短时间内有助于进行秋季血症产前和出生后诊断。两个系统都具有良好的相关性,但CE系统下的解释应该是谨慎的,因为Hb A2明显地与Hb E分离。特别是在α个子血症基因相互作用的情况下,它会影响Hb A2 / e的量。可以通过α/β-珠蛋白链或α/β-mRNA比率之间的强度揭示不同地瘤基因型的鉴定。然而,这些技术都无法准确诊断特定的丘脑血症基因型。特定的地中海贫血突变可以通过DNA分析进行。在β-地中海贫血症中,各种分子技术已用于β-地中海贫血中的点突变检测和α-塞血症中的大缺失检测。所有这些技术都具有一些优点和缺点。最近,已经介绍了通过下一代测序(NGS)对α-和β-血症基因的筛选。该技术可准确诊断常规技术可能被误诊的血症。使用NGS用于筛查地中海贫血的主要限制是其成本仍然是昂贵的。所有服务实验室都强烈建议选择它们是最熟悉的技术,最经济的技术常规使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号